Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma

• Main Authors: Chong, Q.-Y, You, M.-L, Pandey, V, Banerjee, A, Chen, Y.-J, Poh, H.-M, Zhang, M, Ma, L, Zhu, T, Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Bangalore, India, Liu, L, Lobie, P.E
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Published: Impact Journals LLC 2020
• Subjects: epidermal growth factor receptor; epidermal growth factor receptor 2; estrogen receptor; estrogen receptor alpha; her 1 protein; her 3 protein; her 4 protein; small interfering RNA; trastuzumab; trefoil factor 3; tumor marker; unclassified drug; Article; breast cancer cell line; breast carcinoma; cancer growth; cancer resistance; cancer stem cell; cancer survival; cell function; controlled study; disease association; disease marker; drug sensitization; drug targeting; estrogen receptor positive breast cancer; human; human cell; immunoblotting; polymerase chain reaction; protein expression; protein family; protein function; regulatory mechanism; signal transduction; transcription regulation; upregulation; Western blotting
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/174441
• Institution: National University of Singapore

10.18632/oncotarget.18431